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INTRODUCTION
Unexplained health symptoms appear to be ubiquitous to modern war. 1 However, questions remain regarding linkages between military operational deployment and the development of physical or mental health symptoms. An area of particular vulnerability may be neuropsychological functioning. For example, following the 1991 Gulf War (GW), significant subsets of military personnel and veterans reported non-specific health (e.g., headache, fatigue) and cognitive (e.g., memory impairment) symptoms suggestive of possible neural dysfunction. [3] [4] [5] [6] [7] Neuropsychological functioning encompasses cognitive (e.g., memory, attentional, reasoning), perceptual-sensory-motor (e.g., motor speed), and emotional (e.g., mood) behaviors thought to reflect neural integrity. Unresolved issues include whether subjective neuropsychological complaints correspond to objectively measured indices; whether neuropsychological problems can be linked to specific environmental exposures, stress exposures, or other deploymentrelated experiences; and the interaction of deployment with potential risk and resilience factors on neuropsychological functioning.
The work encompassed in this report is now referred to as the Neurocognition Deployment Health Study (NDHS) . To help address the gaps in knowledge described above, the NDHS incorporates prospective administration of performance-based measures of neuropsychological functioning in cohorts of Army Soldiers deploying in support of Operation Iraqi Freedom (OIF) and in a similar group of Soldiers before and after an interval of non-deployment. The objectives of this ongoing study are to (a) examine the impact of combat-zone deployment on neuropsychological outcomes, including neurobehavioral and emotional functioning, (b) examine the impact of deployment-related stress and environmental exposures on neuropsychological outcomes, and (c) identify potential health risk and protective factors relevant to neuropsychological outcomes. A secondary objective of the study is to describe select psychiatric outcomes, the importance of which is suggested by high rates of PTSD and other psychiatric disorders following Iraq deployment.
BODY

Project History
The original SOW described the following elements within a 24-month timeframe: YEAR 1 Phase I Task 1 Proposal phase  and Week 1 Orient project staff to project tasks, training, set-up Task 2 Months 1-4 Phase I pre-deployment, baseline assessment & data collection, creation of database Task 3 Collection of electronic medical/health care record system databases through data requests, transfer of test data to formats readable by statistical software; data entry Task 4 Preliminary analyses of Phase I data collection. YEAR 2 Phase II Task 1 Post-deployment assessment & data collection; collection of electronic deployment-related service information through data requests; data transfer; data entry Task 2 Complete collection of electronic deployment-related service information, data transfer, and data file linking of pre-and post-databases. Task 3 Final data analysis; preparation of reports However, the SOW was later approved to extend to a 60-month time frame, the final 12 months of which reflect a no-cost extension. The 60-month time frame reflects in part modifications to the data collection schedule associated with the deployment rotations of the military units included in the study and initial delays in the study associated with administrative approvals and identification of appropriate military units. In addition, it reflects the addition of a third data collection point for each unit so that longitudinal stability may be assessed and outcomes expanded to include health behaviors and occupational functioning.
The history of the project is as follows: Collection of electronic medical/health care record system databases through data requests, transfer of test data to format readable by statistical software; data entry of data generated relevant to Year 4, Task 3 participants. Data analysis and preparation of final reports.
Progress to date
Progress to date includes accomplishment of all tasks through Year 4. In addition to the elements explicitly listed within the SOW, we have also established an administrative infrastructure, obtained all necessary administrative approvals, and established a Scientific Advisory Council, which meets annually. A manuscript describing the primary neuropsychological Time 1/Time 2 outcomes for Active Duty participants (see Task 3) was published by the Journal of the American Medical Association in August, 2006 (Vol. 296, 519-529) . (Please see appendix) . A manuscript describing rates of baseline posttraumatic stress disorder (PTSD) and the relationship of PTSD symptoms to early life events and unit cohesion is currently in press in the Journal of Traumatic Stress.
With the exception of Time 3 rater-scored Visual Reproduction data, all data collected to date have been entered and subjected to intensive data quality checks. Data management has required extensive effort because of the anomalies regarding participant classification as "deployed" or "nondeployed" and the addition of a second baseline for the 1 st Cavalry unit. However, a comprehensive and synthesized data base had been established. Primary outcomes for Time 1 to Time 2 have been conducted for the Active Duty component. We are currently in the process of completing analyses relevant to secondary objectives (PTSD outcomes) for Time 1 to Time 2 Active Duty comparisons.
Time 1 enrollment totaled 1595 participants. Time 2 assessments have been conducted on all participating units with the exception of a small Air National Guard unit and include a total of 1049 participants to date. Longitudinal retention for Active Duty Soldiers has been approximately 76.7%. Among those who were not retained for Time 2 assessment, the primary reasons for loss to follow-up have been changes in military unit assignments (14%) and separation from service (46.1%). Longitudinal retention of National Guard Soldiers has been lower (61%) and reflects re-organization within the 278th and, more often, separation from the National Guard.
Time 3 (1-year follow-up) in-person assessments were conducted on a much smaller subgroup of active duty soldiers (n=186) who remained in the military with their originating units. In addition, we have completed Time 2 (initial post-deployment) assessment of a brigade that had been assessed previously before and after a period of garrison duty but subsequently deployed.
Unit membership for the original Time 1/Time 2 Active Duty deploying units has been submitted to the US Army Center for Health Promotion and Preventive Medicine to facilitate obtaining appropriate linked environmental data. We are currently summarizing such information to submit for the National Guard units and the active duty unit that deployed between Time 2 and Time 3.
Findings to date
Primary outcomes: Neuropsychological functioning
Findings from multi-level analyses that take into account battalion-level unit membership and demographic covariates indicate that deployment was associated with disadvantages to memory functioning (as measured by a non-computerized word list learning task, WMSIII Verbal Paired Associates I sum and a visual reproduction task, WMS Visual Reproductions delay and savings ratio) and attention (as measured by number of non-response errors on a computerized simple continuous performance task, NES3 CPT), but advantages to reaction time efficiency (ANAM Simple Reaction Time). All other tasks of cognitive efficiency (ANAM) were unaffected. Additionally, deployment was associated with adverse changes in emotional functioning, including symptoms associated with posttraumatic stress disorder (PTSD) and state affect, including POMS Confusion and Tension scores. In contrast, deployment was not associated with changes in measures of state (POMS) depression, vigor, anger, or fatigue, or measures of functional health (SFv12 and MOS Cognitive) including self-perceptions of cognitive, emotional, and physical functional impact.
These findings have been published in the Journal of the American Medical Association (see attachment).
2. Secondary outcomes: PTSD and functioning a. We examined relationships among stressful life events, perceived unit cohesion, and PTSD symptom severity at Time 1 across the entire NDHS cohort. We found that a sizable subset of military personnel (10%) reported significant pre-deployment, stress-related symptoms, as measured by the PCL, a 17-item DSM-based self-report survey, and using the criteria established by Hoge et al. (2004) . Regression analyses revealed that life experiences (beta = 1.20, p <.001) and unit cohesion (beta = -0.35, p < .001) independently predicted PTSD symptoms at baseline, together predicting 22% of the variance, even after taking into account demographics and duty status.
A scientific manuscript describing these findings is currently in press in the Journal of Traumatic Stress.
b. We have completed preliminary analyses examining PTSD symptoms among active duty soldiers. A mixed model MANOVA (deployment x time) revealed that deployment status interacted with time of assessment for PCL total symptom (p <.001), re-experiencing (p < .001), and arousal (p < .001) scores. As shown in the following table, follow-up comparisons suggested that deployment was associated with an increase in PTSD symptom severity on the PCL among deployed soldiers that appears to be driven by specific increases in re-experiencing and arousal symptom clusters. The increase in arousal symptoms is especially relevant to our primary neuropsychological outcomes, which were interpreted to be consistent with an arousal-based stress response. c. Preliminary assessment of available NDHS data suggest that self-reported day-do-day functioning related to cognitive and somatic health problems declined among both deployed and non-deployed active duty participants, but that deployment status did not interact significantly with time. As shown in the following table, there were no significant changes from Time 1 to Time 2 in self-reported mental healthrelated functioning among either deployed or non-deployed participants. These findings highlight the significance of neuropsychological and health-related changes on day-to-day functioning, but raise the question that factors other than deployment status alone might influence such changes. We also queried for health symptoms among deployed soldiers, beginning at their initial postdeployment assessment. The following table depicts the rates at which active duty deployed participants reported frequent health symptoms at postdeployment. Over 10% of the deployed participants reported gastrointestinal symptoms, headaches, muscular discomfort, and joint pains that occurred several times per week; and over 25% reported frequent fatigue and backaches. These health symptoms have been shown to be associated with military stress exposures. 8, 9 Percentage of active duty soldiers (n=654) at postdeployment assessment reporting health symptoms occurring several times per week or more Backaches 29% Fatigue or overtired, lack of energy 25% Joint pains 23% Muscle aches or stiffness 21% Headaches 17% Stomach cramps or excessive gas 12% Numbness in arms/legs 8% Dizziness or feeling light-headed 8% Racing heart 8% Nausea and/or upset stomach 7% Skin rashes, eczema, skin allergies 6% Diarrhea 6% Difficulty breathing or shortness of breath 5% Rapid breathing 5% Common cold or flu 5% Chest pain 4% Irregular beats or "heart flutters" 3%
The next steps in the analyses will be: (1) examination of exposures that predict PTSD (2) examination of the longitudinal associations among neuropsychological functioning, traumatic brain injury, and PTSD; (3) examination of the duty status, comparing the deployed Army National Guard Unit outcomes to those of an Active Duty participants matched as closely as possible for demographics, MOS, and deployment stress exposures; (4) examination of the association between PTSD development and standardized test taking ability among deployed active duty soldiers.
CONCLUSIONS
Process Conclusions
This study has established an effective model of inter-departmental collaboration between VA and DoD. This is a critical accomplishment relevant especially to longitudinal research addressing outcomes throughout both military and post-military life periods.
In addition, the work accomplished has provided a model of how neurobehavioral assessments could potentially be incorporated into more regular surveillance with the military. With memory and other cognitive complaints factoring high among war-zone returnees and being of high relevance to occupational functioning and cognitive readiness, the establishment of neurobehavioral surveillance methodology is significant to force health protection efforts. The methods used in this study are noninvasive and could potentially be implemented in a cost-effective manner on a broader scale.
Scientific Conclusions
Findings to date suggest that there are objective changes in neuropsychological functioning associated with deployment. While at least one is at face value positive (efficiency in simple reaction time), others are negative (less proficient attentional and memory performances, increased emotional symptoms). Taken together, findings raise the question of a biological stress response, involving neurotransmitter/hormonal systems relevant to the neurobehavioral findings listed above. The design elements of a baseline assessment and of a non-deploying comparison sample well-matched to the deploying sample on key demographic and military characteristics suggest that these findings cannot be attributed solely to pre-existing conditions or simply to the passage of time.
The next critical steps will be to examine the secondary outcome, PTSD and the impact of specific risk and resilience factors on the outcomes to determine which individual and deployment-related factors may be serving as critical determinants. For example, our findings suggest that unit cohesion, a modifiable factor, can decrease risk of emotional distress following exposure to stressful life events. Given that we have found an increase in PTSD symptoms over the deployment period, identification of modifiable risk factors for negative emotional outcomes will continue to be of considerable importance in developing preventive health strategies.
The ongoing work will also allow examination of whether these findings are stable over time, if longer-term outcomes can be predicted by early neurobehavioral markers, whether duty status (regular Active Duty versus Guard/Reserve) influences outcomes, and the impact of adverse outcomes on occupational functioning and service utilization with DoD and VA medical care facilities. Finally, our screening for head injury over the deployment period will allow exploration of associations between neurocognitive functioning, traumatic brain injury, and emotional functioning.
